Theodora Anagnostou

Theodora Anagnostou

Hematology Oncology
800 East 28th Street
Suite 39602
Minneapolis, MN 55407

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

Impact of Complete Response on Long-Term Survival in Patients with Relapsed or Refractory Large B-cell Lymphoma: A Center for International Blood and Marrow Transplant Research Prospective Study and Systematic Literature Review/Meta-Analysis.

Impact of Complete Response on Long-Term Survival in Patients with Relapsed or Refractory Large B-cell Lymphoma: A Center for International Blood and Marrow Transplant Research Prospective Study and Systematic Literature Review/Meta-Analysis.

Journal: Transplantation and cellular therapy
Published: August 12, 2025

CD8+CD38+ T cells identify functional high-risk multiple myeloma after autologous transplant: BMT CTN 0702 correlates.

CD8+CD38+ T cells identify functional high-risk multiple myeloma after autologous transplant: BMT CTN 0702 correlates.

Journal: Blood neoplasia
Published: August 11, 2025

Diagnosis and management of bispecific T cell-engaging antibody toxicity: A primer for emergency physicians.

Diagnosis and management of bispecific T cell-engaging antibody toxicity: A primer for emergency physicians.

Journal: Cancer treatment reviews
Published: September 11, 2024

Cancer vaccines and the future of immunotherapy.

Cancer vaccines and the future of immunotherapy.

Journal: Lancet (London, England)
Published: May 24, 2024

Brentuximab vedotin as a bridge to combination chemotherapy in gray zone lymphoma with severe liver impairment: a case report.

Brentuximab vedotin as a bridge to combination chemotherapy in gray zone lymphoma with severe liver impairment: a case report.

Journal: Frontiers in oncology
Published: July 06, 2023

Demographics, Motivations, and Experiences of Participants in Transplantation or Cellular Therapy Fellowships.

Demographics, Motivations, and Experiences of Participants in Transplantation or Cellular Therapy Fellowships.

Journal: Transplantation and cellular therapy
Published: December 01, 2022

Characterization of immune exhaustion and suppression in the tumor microenvironment of splenic marginal zone lymphoma.

Characterization of immune exhaustion and suppression in the tumor microenvironment of splenic marginal zone lymphoma.

Journal: Leukemia
Published: September 26, 2022

In CAR T cell-treated lymphomas, the T cell rich get richer.

In CAR T cell-treated lymphomas, the T cell rich get richer.

Journal: Nature medicine
Published: August 29, 2022

Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma.

Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma.

Journal: Leukemia
Published: July 03, 2022

Phenotype, Function, and Clinical Significance of CD26+ and CD161+Tregs in Splenic Marginal Zone Lymphoma.

Phenotype, Function, and Clinical Significance of CD26+ and CD161+Tregs in Splenic Marginal Zone Lymphoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 29, 2022

Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma.

Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma.

Journal: Transplantation and cellular therapy
Published: March 28, 2022

Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy.

Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 03, 2021
Showing 1-12 of 30

Last Updated: 09/26/2026